Ruth Morrell - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2011	1
2013	1
2015	1
2018	1
2022	0

Page 1

Nonfamilial, MPL S505N-Mutated Essential Thrombocythaemia.

Morrell R, Langabeer SE, Smyth L, Perera M, Crotty G. Morrell R, et al. Case Rep Hematol. 2013;2013:729327. doi: 10.1155/2013/729327. Epub 2013 Jul 18. Case Rep Hematol. 2013. PMID: 23970983 Free PMC article.

Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.

O' Reilly E, Dhami SPS, Baev DV, Ortutay C, Halpin-McCormick A, Morrell R, Santocanale C, Samali A, Quinn J, O'Dwyer ME, Szegezdi E. O' Reilly E, et al. Among authors: morrell r. Sci Rep. 2018 Oct 25;8(1):15752. doi: 10.1038/s41598-018-33982-y. Sci Rep. 2018. PMID: 30361682 Free PMC article.

The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis.

Dijk Mv, Murphy E, Morrell R, Knapper S, O'Dwyer M, Samali A, Szegezdi E. Dijk Mv, et al. Among authors: morrell r. Cancers (Basel). 2011 Mar 15;3(1):1329-50. doi: 10.3390/cancers3011329. Cancers (Basel). 2011. PMID: 24212664 Free PMC article.

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

McCarron SL, Langabeer SE, Bolger K, Haslam K, Crampe M, Kelly J, Morrell R. McCarron SL, et al. Among authors: morrell r. Med Oncol. 2015 Feb;32(2):452. doi: 10.1007/s12032-014-0452-3. Epub 2015 Jan 13. Med Oncol. 2015. PMID: 25579165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results